So far, the liver CEACAM1 knockout mice provide an in vivo proof of the key role of impaired hepatic insulin clearance and hyperinsulinemia in the pathogenesis of secondary hepatic insulin resistance. This evidence concerns the gene CEACAM1 and Insulin resistance.